Date: Sep 24, 2019 12:00 PM - 01:00 PM
Registration closes on Oct 09, 2019 12:00 AM
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To learn more about the specific program information, including universal activity numbers (UAN's) and learning objectives, please expand the modules below. Following successful completion of an evaluation, CE credit will be automatically reported to NABP through the CPE Monitor system, using the NABP ePID numbers and date of birth (MMDD) stored in participants' user profiles. Follow this link to learn more about CPE Monitor and the credit reporting process » Participants are responsible for ensuring receipt of credit; no credit can be corrected or awarded if more than 60 days have passed from the date of the event or if the home study is expired.
It is the policy of St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating in this program are expected to disclose to the program audience any real or apparent conflicts of interest related to the content of the presentation.
Requirements for CE Credit
Registration closes on Oct 09, 2019
at 12:00 AM
- Review the updated 2019 worldwide Global Initiative for Asthma (GINA) guidelines.
- Identify which patients are candidates for PRN ICS/LABA therapy.
- Briefly review available and emerging targeted therapies for severe asthma.
Suzanne G. Bollmeier, Pharm.D., FCCP, BCPS, AE-C